Skip to main content
Vineet Laboratories Limited logo

Vineet Laboratories Limited — Investor Relations & Filings

Ticker · VINEETLAB ISIN · INE505Y01010 LEI · 98450053FEE2D64C6147 BSE.NS Manufacturing
Open in API
Filings indexed 278 across all filing types
Latest filing 2022-01-06 Regulatory Filings
Country IN India
Listing BSE.NS VINEETLAB

About Vineet Laboratories Limited

http://vineetlabs.co.in/

Vineet Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and API intermediates. The company focuses on producing high-quality chemical compounds through advanced research and development, catering to diverse therapeutic segments including anti-retroviral, anti-diabetic, and anti-hypertensive treatments. Its core operations involve the synthesis of complex molecules and fine chemicals, supported by manufacturing facilities that adhere to rigorous quality management systems. Vineet Laboratories provides custom synthesis and contract manufacturing services, positioning itself as a technical partner for global healthcare organizations. The company emphasizes process optimization and cost-effective production to deliver reliable chemical solutions for large-scale pharmaceutical applications.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, certifying that no securities were received for dematerialisation/rematerialisation during the quarter ended 31.12.2021. It is a compliance certificate addressed to the Compliance Officer and does not contain financial statements or detailed financial data. The document length is short (984 characters) and it serves as an attestation or confirmation letter rather than a full report. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2022-01-06 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the closure of the trading window for insiders due to upcoming financial results. It references regulatory compliance with SEBI insider trading regulations and mentions the upcoming declaration of quarterly financial results but does not contain any financial data or the results themselves. The document length is only 1821 characters, which is quite short and consistent with an announcement rather than a full report. There is no detailed financial information or analysis present. Therefore, this document is an announcement related to trading restrictions ahead of financial results, which fits best under Regulatory Filings (RNS) as it is a compliance-related notification to the stock exchanges.
2021-12-30 English
Related Party Transactions
Regulatory Filings
2021-12-09 English
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is a communication addressed to stock exchanges (BSE and NSE) regarding the outcome of a Board Meeting held on 10th November 2021. It specifically mentions the approval of unaudited standalone financial results for the quarter and half year ended 30th September 2021, along with the limited review reports by statutory auditors. The document also includes a resignation announcement of a company secretary. The presence of unaudited financial results for a quarter and half year period, along with limited review reports, indicates this is an Interim / Quarterly Report filing. The document length (15,000 characters) and inclusion of financial data support this classification. Therefore, the filing type is Interim / Quarterly Report (IR). H1 2022
2021-11-10 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a communication addressed to stock exchanges (BSE and NSE) regarding the outcome of a Board Meeting held on 10th November 2021. It mentions approval of unaudited standalone financial results for the quarter and half year ended 30th September 2021, along with limited review reports by statutory auditors. It also announces the resignation of a company secretary. The document includes financial data tables for the quarter and half year. The content aligns with a regulatory announcement of quarterly financial results and related board decisions, typical of an Interim / Quarterly Report filing. The document is substantive (15,000 characters) and contains actual financial data, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2022
2021-11-10 English
Board Meeting — Financial Results
Regulatory Filings Classification · 100% confidence The document text is extremely short (69 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any regulatory information. Given the lack of content, this document does not fit any specific report category and defaults to the fallback category for miscellaneous filings.
2021-11-01 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.